rxstat › Classes › Antithrombotic Agents
Antithrombotic Agents: shortage status in Canada
8 of the 25 antithrombotic agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Nadroparin (Fraxiparine) Widespread shortage 7 of 8 reported products affected
Ticagrelor Widespread shortage 2 of 4 reported products affected · est. return Oct 2, 2026
Clopidogrel (Plavix) Partial shortage 4 of 18 reported products affected · est. return Nov 10, 2026
Dabigatran Etexilate (Pradaxa) Partial shortage 2 of 6 reported products affected · est. return Oct 9, 2026
Edoxaban (Lixiana) Partial shortage 2 of 8 reported products affected · est. return Oct 2, 2026
Rivaroxaban (Xarelto) Partial shortage 4 of 18 reported products affected · est. return Nov 30, 2026
Ticlopidine Partial shortage 1 of 1 reported products affected
Warfarin (Coumadin) Partial shortage 1 of 23 reported products affected
Tinzaparin (Innohep) Shortage anticipated 0 of 11 reported products affected
Abciximab (Reopro) Discontinued 0 of 1 reported products affected
Acenocoumarol (Sintrom) Discontinued 0 of 2 reported products affected
Acetylsalicylic Acid Dipyridamole (Aggrenox) Discontinued 0 of 2 reported products affected
Alteplase (Cathflo) No current shortage
Apixaban No current shortage
Argatroban No current shortage
Bivalirudin (Angiomax) No current shortage
Dipyridamole (Persantine) No current shortage
Enoxaparin (Lovenox) No current shortage
Epoprostenol (Flolan) No current shortage
Eptifibatide (Integrilin) Discontinued 0 of 4 reported products affected
Heparin No current shortage
Heparin Dextrose No current shortage
Heparin Dibasic Citric Acid Dextrose No current shortage
Rivaroxaban (Xarelto) Discontinued 0 of 1 reported products affected
Water Alteplase (Activase Rt-Pa) No current shortage
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.